This completed Phase 3 trial tested whether two widely available drugs—fluvoxamine (an antidepressant) and metformin (a diabetes drug)—can reduce fatigue and other symptoms in people with long COVID. 399 adults with confirmed prior COVID-19 infection and persistent symptoms took …
Phase: PHASE3 • Sponsor: Cardresearch • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC